Earlier reported small interfering RNA (siRNA) high-throughput screens, identified seven-transmembrane superfamily member 3 (TM7SF3 ) as a novel inhibitor of pancreatic β-cell death. Here we show that TM7SF3 maintains protein homeostasis and promotes cell survival through attenuation of ER stress. Overexpression of TM7SF3 inhibits caspase 3/7 activation. In contrast, siRNAmediated silencing of TM7SF3 accelerates ER stress and activation of the unfolded protein response (UPR). This involves inhibitory phosphorylation of eukaryotic translation initiation factor 2α activity and increased expression of activating transcription factor-3 (ATF3), ATF4 and C/EBP homologous protein, followed by induction of apoptosis. This process is observed both in human pancreatic islets and in a number of cell lines. Some of the effects of TM7SF3 silencing are evident both under basal conditions, in otherwise untreated cells, as well as under different stress conditions induced by thapsigargin, tunicamycin or a mixture of pro-inflammatory cytokines (tumor necrosis factor alpha, interleukin-1 beta and interferon gamma). Notably, TM7SF3 is a downstream target of p53: activation of p53 by Nutlin increases TM7SF3 expression in a time-dependent manner, although silencing of p53 abrogates this effect. Furthermore, p53 is found in physical association with the TM7SF3 promoter. Interestingly, silencing of TM7SF3 promotes p53 activity, suggesting the existence of a negative-feedback loop, whereby p53 promotes expression of TM7SF3 that acts to restrict p53 activity. Our findings implicate TM7SF3 as a novel p53-regulated pro-survival homeostatic factor that attenuates the development of cellular stress and the subsequent induction of the UPR.
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Earlier reported small interfering RNA (siRNA) high-throughput screens, identified seven-transmembrane superfamily member 3 (TM7SF3 ) as a novel inhibitor of pancreatic β-cell death. Here we show that TM7SF3 maintains protein homeostasis and promotes cell survival through attenuation of ER stress. Overexpression of TM7SF3 inhibits caspase 3/7 activation. In contrast, siRNAmediated silencing of TM7SF3 accelerates ER stress and activation of the unfolded protein response (UPR). This involves inhibitory phosphorylation of eukaryotic translation initiation factor 2α activity and increased expression of activating transcription factor-3 (ATF3), ATF4 and C/EBP homologous protein, followed by induction of apoptosis. This process is observed both in human pancreatic islets and in a number of cell lines. Some of the effects of TM7SF3 silencing are evident both under basal conditions, in otherwise untreated cells, as well as under different stress conditions induced by thapsigargin, tunicamycin or a mixture of pro-inflammatory cytokines (tumor necrosis factor alpha, interleukin-1 beta and interferon gamma). Notably, TM7SF3 is a downstream target of p53: activation of p53 by Nutlin increases TM7SF3 expression in a time-dependent manner, although silencing of p53 abrogates this effect. Furthermore, p53 is found in physical association with the TM7SF3 promoter. Interestingly, silencing of TM7SF3 promotes p53 activity, suggesting the existence of a negative-feedback loop, whereby p53 promotes expression of TM7SF3 that acts to restrict p53 activity. Our findings implicate TM7SF3 as a novel p53-regulated pro-survival homeostatic factor that attenuates the development of cellular stress and the subsequent induction of the UPR. Proper functionality and robustness of protein homeostasis (proteostasis) is regulated by several defense mechanisms. [1] [2] [3] These include the heat-shock response (HSR) 4 and the unfolded protein responses (UPRs). 5 The UPR is an elaborate adaptive response that evolved to restore protein-folding homeostasis under conditions that challenge ER function and induce ER stress. 5, 6 It involves dissociation of BiP/GRP78 from the three principal ER stress sensors: PKRlike ER kinase (PERK), inositol-requiring kinase-1 (IRE1) and activating transcription factor-6 (ATF6), and activation of the signal transduction pathways emanating from these stress sensors. 5, 7 The main role of the UPR is to restore ER homeostasis by reducing protein load, and increasing ERfolding capacity and misfolded protein degradation. Attenuation of protein translation is executed by PERK through phosphorylation of the eukaryotic translation initiation factor 2α (eIF2α), whereas the two other branches of the UPR increase ER function by upregulating the expression of ER chaperones and the ER-associated protein degradation machinery. The combined action of these cascades serves to reduce ER stress. However, sustained ER stress induces apoptotic cell death through increased expression of ATF4, ATF3 and the C/EBP homologous protein (CHOP). [8] [9] [10] The tumor suppressor p53 is activated in response to numerous cellular insults, including ER stress, and may lead to the repair of the cellular damage, cell-cycle arrest, apoptosis or senescence.
11 p53 attenuates the UPR caused by ER stress as evidenced by augmented alternative splicing of X-box binding protein-1 (XBP1), the transcription factor that executes the UPR, in p53-deficient mice. 12 Accordingly, reduced expression of BiP/GRP78 is observed in liver and pancreas of p53 knockout mice subjected to ER stress in vivo, but not in spleen and lung. 13 These findings indicate that p53 deficiency may confer hypersensitivity to ER stress and the UPR in selected tissues. In addition, p53 plays a more general role in apoptosis induced by sustained and unresolved UPR. [14] [15] [16] Under such conditions, elevation in p53 expression in certain cell types, including MEF, MCF-7 and HCT116 cells, is accompanied by upregulation of apoptosis modulators such as p53-upregulated modulator of apoptosis (PUMA) and NOXA, a BH3-Only Member of the Bcl-2 Family. 15 Of interest, PUMA has been implicated as a key player in apoptosis of pancreatic β-cells as a result of palmitate-induced ER stress.
Pancreatic β-cells are particularly susceptible to cellular stress due to their high rate of protein synthesis. 18, 19 Proinflammatory cytokines are prominent inducers of ER stress and pancreatic β-cells death, through a number of pathways, including induction of the transcription factors nuclear factor kappa B (NF-κΒ), and signal transducer and activator of transcription 1 (STAT-1). 20 STAT-1 activates Jun N-terminal kinase, whereas NF-κΒ promotes the production of nitric oxide (NO), as well as depletion of calcium from the ER that results in ER stress and subsequent apoptosis. 8, 21 In search for novel players involved in stress-induced death of pancreatic β-cells, we conducted high-throughput screens (HTSs) for the effect of specific small interfering RNAs (siRNAs) on the survival of the MIN6 β-cell line 22 and human pancreatic islets treated with pro-inflammatory cytokines. These studies revealed several genes that had not been previously associated with cytokineinduced β-cell death. 22, 23 Among them were Otubain-2,
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Nedd4 family-interacting protein-1 (ref. 24 ) and the seventransmembrane superfamily member 3 protein (TM7SF3). 25 In a previous study, 22 we have shown that TM7SF3 is a potential new player in the inhibition of cytokine-induced death, and in the promotion of insulin secretion from pancreatic β-cells. Its main action was associated with maintaining cellular reducing power within physiological levels and reducing the cellular content of pro-apoptotic proteins such as FAS, Fasassociated via death domain and caspase-8. 22 Here we show that TM7SF3 maintains protein homeostasis and promotes survival of different cell types through attenuation of ER stress and the subsequent induction of the UPR. We further show that TM7SF3 is a downstream transcriptional target of p53. Our findings implicate TM7SF3 as a novel pro-survival homeostatic factor, regulated by p53, that attenuates the development of cellular stress.
Results
TM7SF3 inhibits cell death. Earlier reported siRNA HTSs 22, 23 identified novel genes involved in cytokineinduced death of the MIN6 β-cell line and human pancreatic islets. One of the top 'hits' was TM7SF3, a protein of unknown function, whose silencing inhibited insulin secretion and promoted cytokine-induced death of pancreatic β-cells.
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To study its underlying mode of action, TM7SF3 was overexpressed in dispersed human islets treated with cytokines. Overexpression of GFP (control) plasmid significantly increased basal caspase activity in dispersed human islets, presumably owing to the stress induced by the transfection procedure in these hypersensitive cells; however, overexpression of TM7SF3 decreased by~65%, this elevated activity (Figure 1a) . A similar~45% decrease in caspase 3/7 activity was observed in cells treated with cytokines. Smaller effects were observed in MIN6 cells overexpressing TM7SF3 that were treated with cytokines ( Figure 1b) . We have previously shown 22 that the increase in caspase 3/7 activity induced by cytokines and other stress inducers reflects increased cellular apoptosis, at least in MIN6 cells, as evident by their altered cellular morphology, reduced cell viability and cellular reducing power, and the increase in the fraction of apoptotic (Annexin V-positive) cells, determined by FACS analysis. 22 The protective effects of TM7SF3 on cell viability were not restricted to β-cells. Silencing of TM7SF3 in U2-OS cells almost completely abolished the expression of the protein (Figure 1c) , and was accompanied by a marked twofold increase in basal caspase 3/7 activity ( Figure 1d ) and a significant 50% reduction in cell number (Figure 1e ). Accordingly, overexpression of TM7SF3-Myc or TM7SF3-Flag in HEK293 cells significantly reduced caspase activity mainly following treatment with cytokines, although transfection of an 'empty' (control) vector was without effect (Figure 1f) . Collectively, these results suggest that inhibition of apoptosis and increased cellular viability mediated by TM7SF3 is a general phenomenon, taking place in a variety of cell types.
Silencing of TM7SF3 increases iNOS mRNA levels and nitric oxide production. To determine whether silencing of TM7SF3 promotes apoptosis through the induction of endoplasmic reticulum (ER) stress, we studied the effects of silencing of TM7SF3 on activation of iNOS and production of NO that are key contributors to ER stress and apoptosis in pancreatic β-cells 26 and other cell types. 27, 28 Human pancreatic islets were treated with 100 nM of thapsigargin -an inhibitor of the sarco/ER Ca 2+ ATPase, which depletes the ER Ca 2+ stores. 29 Such treatment did not increase iNOS transcription on its own; however, when it was combined with silencing of TM7SF3, a marked~10-fold increase in the transcription of iNOS could be observed (Figure 2a ). Treatment of human islets with cytokines for 24 h significantly increased iNOS mRNA levels, but silencing of TM7SF3 did not exert any further effect (Supplementary Figure 1S) . On the other hand, silencing of TM7SF3 in MIN6 cells in the presence of cytokines, resulted in a significant increase of 1.7-fold in iNOS mRNA ( Figure 2b ) that was accompanied by a significant~2-fold increase in NO production compared with control ( Figure 2c ). The ability of TM7SF3 to suppress iNOS expression seems to be a general phenomenon. Thus, silencing of TM7SF3 in HepG2 and U2-OS cells caused a marked 4-12-fold increase in iNOS mRNA levels (Figures 2d and e). These findings suggest that TM7SF3 can inhibit iNOS expression and NO production both under basal and stress conditions. TM7SF3 inhibits ER stress and the unfolded protein response. A number of cell types, including pancreatic β-cells, are highly sensitive to the induction endoplasmic reticulum (ER) stress. 21 Given that TM7SF3 acted as an antiapoptotic gene and an inhibitor of nitric oxide production that promotes ER stress, we studied its effects on CHOP, a key inducer of apoptosis as a result sustained activation of the UPR. As shown in Figure 3a ER stress and the induction of the UPR are accompanied by attenuation of global protein translation through phosphorylation and inhibition of the eIF2α. 34 To determine whether TM7SF3 affects this aspect of the UPR, we studied the state of phosphorylation of eIF2α. As shown in Figure 4f , silencing of TM7SF3 in MIN6 cells promoted the phosphorylation (inhibition) of eIF2α already at the basal state, and this effect was further potentiated in the presence of thapsigargin, suggesting that TM7SF3 is required for maintenance of eIF2α in its dephosphorylated active state.
p53 is an upstream regulator of TM7SF3. The above findings suggest that TM7SF3 dampens ER stress and the subsequent activation of the UPR. We therefore sought to unravel the mechanisms that regulate the expression of TM7SF3. As shown in Figure 5a , treatment of MIN6 cells with cisplatin 35 or doxorubicin 36 increased TM7SF3 mRNA levels, suggesting that it could be upregulated also under certain types of genotoxic stress. Interestingly, thapsigargin, tunicamycin, cytokines and etoposide, 37 failed to increase or even slightly decreased the mRNA levels of TM7SF3 (Figure 5a ), indicating that only a selected set of stress inducers affect TM7SF3 expression. Of note, a number of the agents that promoted expression of TM7SF3, also increased transcription of p21 (Figure 5b ), a known downstream target of p53. 38 Indeed, silencing of p53 in HepG2 and other cells, that abolished p53 protein expression (Supplementary Figure 3S) , significantly reduced the mRNA levels of both TM7SF3 and p21, stimulated by the different stress inducers (Figures 5c and d) . The same general trend was also observed at the protein level (Figure 5e ), where doxorubicin and etoposide, but not thapsigargin or tunicamycin increased the protein level of both TM7SF3 and p53. Of note, there was no complete correlation between the effects of the different stress inducers on mRNA and protein levels of TM7SF3, p21 and p53. For example, etoposide was a strong inducer of TM7SF3 expression, mainly at the protein level, although having a rather modest effect on the expression of p53, while the opposite was true for cis-platinum. These findings suggest that somewhat different pathways regulate the expression of TM7SF3 and p53. Given that certain inducers of p53 promote transcription and expression of TM7SF3, and given that ER and genotoxic stress up-regulates p53, 15, 16, 39 we set out to explore the possible involvement of p53 in the regulation of TM7SF3 transcription.
We found that Nutlin-3a, an inhibitor of MDM2, and a potent inducer of p53, 40 increased the amounts of TM7SF3 mRNA and protein. Treatment of human islets or HepG2 cells with Nutlin increased approximately threefold TM7SF3 mRNA in a time-dependent manner (Figures 6a and b) . A marked increase in p21 mRNA was observed as well (Figures 6c  and d) . Silencing of p53 markedly reduced the effects of Nutlin (Figures 6a and b) , indicating that indeed they were mediated by p53. Similar results were observed in HCT116 (Supplementary Figures 4Sa and b ) and MCF10A cells ( Supplementary Figures 4Sc and d) . Nutlin also increased twofold the protein levels of TM7SF3, in association with a marked increase in expression of p53 itself (Figure 6e ). Given that silencing of TM7SF3 promoted iNOS transcription , d and e) . Alternatively, the medium was collected, and the concentration of nitrite was measured by Griess assay (c). Bar graphs are the mean ± S.E.M. of three independent experiments in duplicates. *Po0.05; ***Po0.001 versus non-targeting siRNA assayed under the same conditions. Results in a were obtained in three (out of four batches) of human islets Figure 2 ) and given that suppression of iNOS transcription is linked to p53 activity, 41 we could show that indeed Nutlin, induced TM7SF3 mRNA and inhibited transcription of NOS2 (Figure 6f ), an effect that was abolished upon silencing of p53 (Figure 6g) . Similarly, silencing of TM7SF3 increased CHOP mRNA levels in HepG2 cells treated with doxorubicin, and this effect was also abolished upon silencing of p53 (Figure 6h) .
Analysis of the TM7SF3 gene identified three sites that could function as potential p53-binding sites, located respectively, 4300 and 180 bp upstream or 1000 bp downstream of the transcription start site (TSS) of TM7SF3 (site-3 is within the first intron, Figure 7a ). To determine whether p53 directly regulates TM7SF3 transcription, MCF10A cells were subjected to chromatin immunoprecipitation (ChIP) 42 with antip53 or control antibodies. The ChIP analysis (Figure 7b ) revealed~5-fold enrichment in p53 binding to the third site of the TM7SF3 gene, versus~7-and 60-fold enrichment in p53 binding to the promoter regions of CD95 (ref. 43 ) and p21, 38 respectively, both being known targets of p53. These finding suggest that TM7SF3 may be a direct target of p53 that binds to site-3 of the TM7SF3 gene.
TM7SF3 regulates p53 activity. Feedback regulatory loops represent a common paradigm in biological systems. Therefore, we asked whether TM7SF3 could modulate p53 activity. Indeed, silencing of TM7SF3 markedly potentiated the stimulatory effect of stress inducers on p53 activity, as determined by increased p21 mRNA levels ( Figure 8 ). This effect was observed both in HepG2 (Figure 8a ), MIN6 ( Figure 8b ) and U2-OS cells (Figure 8c ), under basal conditions (Figure 8c ), as well as in cells treated with doxorubicin ( Figure 8a ) or with cytokines ( Figure 8b ). As expected, silencing of p53 eliminated the increase in p21 mRNA (Figure 8d ). Collectively, these findings suggest that p53 and TM7SF3 generate a negative regulatory feedback loop, whereby p53 promotes the expression of TM7SF3, that acts as an inhibitor of p53 activity.
Discussion
The present work highlights the role of TM7SF3 as a novel regulator of ER stress and the UPR in pancreatic β-cells and other cell types. The results indicate that silencing of TM7SF3 promotes the induction of ER stress under basal conditions, and potentiates the effects of known ER stress inducers such as cytokines, thapsigargin and tunicamycin. Lack of TM7SF3 activates NO production and the PERK arm of the UPR that involves inhibition of eIF2α activity, enhanced expression of ATF4 and ATF3, and induction of CHOP that culminates in apoptosis. These observations implicate TM7SF3 itself as an inhibitor of ER stress and a promoter of cell survival. Furthermore, TM7SF3 seems to be both a positive downstream direct target and a negative regulator of p53, implicating the existence of a regulatory network that controls expression of both proteins.
Little is known about TM7SF3 and its biological functions. Our interest in this protein emerged when our earlier siRNA screen revealed that TM7SF3 acts as an anti-apoptotic gene in pancreatic β-cells. 22 This was evident by the increase in caspase 3/7 activity upon silencing of TM7SF3 both at the basal level and under stress induced by cytokines. 22 We could corroborate these findings in the present work by showing that overexpression of TM7SF3 in human pancreatic islets and in the MIN6 β-cell line inhibits caspase 3/7 activity, both under basal conditions and following induction of ER stress. We could further show that this is a general phenomenon, taking place in Figure 5 Effects of stress inducers on mRNA levels of TM7SF3 and p21. MIN6 cells (a and b), HepG2 sh-con or HepG2 sh-p53 cells (c and d), as well as naive HepG2 cells (e) were treated with the indicated stress inducers: cis-platinum − 6 μg/ml (24 h); etoposide -2 μM (24 h); doxorubicin − 1 μM (24 h); thapsigargin 100 nM (8 h); tunicamycin (Tu) 2 μg/ml (8 h) and Cytomix '1X' (5 h) or were left untreated. mRNA levels of TM7SF3 (a and c) and p21 (b and d) were quantified by qRT-PCR. Total cell extracts were resolved by SDS-PAGE and immunoblotted with the indicated antibodies (e). Bar graphs are the mean ± S.E.M. of three independent experiments in duplicates. *Po0.05; **Po0.01; ***Po0.001 versus non-treated cells assayed under the same conditions TM7SF3, a novel p53 target, attenuates the UPR R Isaac et al a number of diverse cell types, including HEK and U2-OS cells. Two microarray analyses of luminal breast tumors 44 and testicular germ cell tumors 45 revealed upregulation of TM7SF3 transcription. These studies suggest, though not proven, that TM7SF3 might function as a pro-survival protein and support our data that TM7SF3 could exert anti-apoptotic functions.
Silencing of TM7SF3 promotes ER stress stimulated by different stress inducers, as evident by the activation of iNOS and the increased production of NO observed in a number of cell lines, as well as in human pancreatic islets. Induction of the UPR is a natural outcome of ER stress. Among the three main branches that execute the UPR, silencing of TM7SF3 only affects the PERK pathway, although having little or no effect on the ATF6 and the IRE1α arms. Preferential activation of a selected branch of the UPR network is a known phenomenon. For example, the dominant effect of the UPR in photoreceptors of P23H rhodopsin knock-in mice involves the preferential use of IRE1-mediated induction of XBP1. 46 Similarly, there is a direct role for the PERK pathway in prion disease pathogenesis, although the IRE1 arm is dispensable in this process. 47, 48 Silencing of TM7SF3 significantly activates the PERK pathway, resulting in the inhibition of eIF2α and activation of ATF4, ATF3 and CHOP, already at basal state, in different cell types. These results suggest that even without external induction of ER stress, TM7SF3 helps in maintaining the cells in unstressed conditions, suggesting that it plays a significant role in keeping cellular homeostasis. These effects of TM7SF3 are accentuated in the presence of stress inducers. Three such inducers were used to promote the UPR: thapsigargin, 29 tunicamycin 49 and cytokines. 21 Our data demonstrate that silencing of TM7SF3 had different effects Figure 6 Effects of Nutlin or silencing of p53 on mRNA levels of TM7SF3, p21, iNOS and CHOP. Human islets (a and c) were transfected for 24 h with 25 nM of p53-siRNA or with a non-targeting siRNA (control). Cells were then treated with nutlin (10 μM) for the indicated periods of time. Alternatively, HepG2 sh-con or HepG2 sh-p53 cells (b, d and g), naive HepG2 (e) or HCT116 cells (f) were treated with Nutlin (10 μM) for 24 h (e) or for the indicated periods of time (a-d, f and g). In parallel, HepG2 sh-control or HepG2 sh-p53 cells were transfected for 48 h with 25 nM of TM7SF3-siRNA or with a non-targeting control sequence. Then the cells were treated with doxorubicin (2 μM; 24 h) (h). RNA was extracted from all cells and quantification of the indicated mRNAs was carried out by qRT-PCR (a-d, f-h). Alternatively, total cell extracts were resolved by SDS-PAGE and immunoblotted with the indicated antibodies (e). Bar graphs are the mean ± S.E.M. of at least three independent experiments. *Po0.05, **Po0.01, ***Po0.001 versus non-targeting siRNA assayed under the same conditions on elements along the PERK pathway, depending on the nature of the stress being inflicted upon the cells. Although silencing of TM7SF3 potentiated the effects of all stress inducers on CHOP expression, analysis of ATF4, the upstream regulator of CHOP, revealed a somewhat different picture. Thus, when cells were subjected to a strong ER stress (e.g., upon treatment with tunicamycin), the increase in ATF4 transcription was already maximal and silencing of TM7SF3 had little additional contribution. However, when the ER stress was mild (e.g., upon treatment with thapsigargin), then silencing of TM7SF3 had a potentiating effect. These findings suggest that lack of TM7SF3 supports the induction of ER stress and the UPR, although it is not a strong stress inducer on its own.
Some inducers of ER stress, such as thapsigargin, tunicamycin or cytokines, reduce the mRNA levels of TM7SF3, yet other stress inducers such as doxorubicin 50 had no effect or even upregulated TM7SF3 mRNA and protein levels. Given that all these inducers activate the UPR, 21, 29, 49, 51 we conclude that TM7SF3 does not belong to the set of genes that are activated as part of the UPR (e.g., certain chaperons). We could show, however, that TM7SF3 transcription is directly regulated by p53. This is based on our findings that inducers of p53, such as Nutlin, promoted the accumulation of TM7SF3 mRNA and protein, whereas silencing of p53 reduced TM7SF3 mRNA. Furthermore, ChIP analysis revealed a direct interaction of p53 with site-3 of the TM7SF3 gene, localized 1000 bp downstream of the TSS of TM7SF3, within the first intron. As p53 supports TM7SF3 transcription at basal state, it suggests that TM7SF3 belongs to the set of genes that help maintain proteostasis and are p53 targets under basal conditions. The fact that p53 promotes expression of TM7SF3, that attenuates the UPR, is in line with the role of p53 as a suppressor of the UPR. 12, 13 For example, E2F1, whose activity is repressed upon activation of p21 by p53, 52, 53 inhibits transcription of GRP78/BiP, 54 thus stimulating the propagation of the UPR. This suggests a molecular link between activation of the p53/p21-signaling pathway and attenuation of the UPR, as a result of E2F1 inhibition and GRP78/BiP accumulation. Still, our findings do not implicate p53 as the sole inducer of TM7SF3 expression because some inducers of p53 fail to promote TM7SF3 expression, indicating that this gene is subject to regulation by other transcription factors as well.
Of interest, TM7SF3 itself presumably acts to restrict p53 activity, implicating the existence of a negative-feedback loop whereby the pro-apoptotic p53 promotes expression of the pro-survival gene TM7SF3 that acts to inhibit p53 expression. The existence of such regulatory loop could serve to maintain the levels of TM7SF3 within a confined range and prevent overproduction of the protein under stress conditions. In summary, the present study highlights the role of TM7SF3, as a regulator of cellular homeostasis that helps in inhibiting the development of ER stress and the subsequent activation of the UPR both under basal conditions and following the induction of cellular stress. It implicates this protein as being a downstream target of p53, thus revealing the existence of a novel link between p53, ER stress and the UPR, with TM7SF3 playing a central role in this network. Antibodies. Polyclonal CHOP (SC-793) and ATF3 (SC-188) antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). ATF4 (#11815), eIF2α and phospho-eIF2αSer51 (#339) antibodies were from Cell signaling (Beverly, MA, USA). Monoclonal GAPDH (MAB374) antibodies were from Millipore (Billerica, MA, USA). Rabbit polyclonal TM7SF3 antibodies were generated by Sigma (Rehovot, Israel) against a peptide (CIKELFQKEQPAGERTPL) at the C-terminal end of TM7SF3. Peroxidase-conjugated affinity purified goat anti-mouse and goat anti-rabbit were from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). 31-2008-413 . Islets were cultured at 37°C in a 5% CO 2 humidified atmosphere in CMRL 1066 medium containing 10% (v/v) FBS, 2 mM L-glutamine, 100 units per ml penicillin, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin and 40 μg/ml gentamycin. The medium was changed every other day. Human islets studies received the WIS Ethics Committee approval. Intact human islets were dispersed by a 4 min incubation at 37°C with 1 mg/ml trypsin/EDTA and by passing the cells twice through a 21 G needle. Trypsinized islets were washed with CMRL 1066 medium containing 10% FBS, and were resuspended in CMRL 1066 containing 10% FBS.
Cloning of mouse TM7SF3. The DNA encoding mouse TM7SF3 (GI:119964708) was cloned from total mouse pancreatic islets cDNA by PCR using the following primers: 5′-ACGAATTCATGTGGCGGCTGCGCCTGCTG GTCCTAGCGGTGCTGGCGGCGGG CAGCGCCGAGGCCCAGGCGAACTCCAG CGACGGTT-3′ and 5′-GTCGACGCAGAAGCAAGGGTGTCCT-3′. PCR products were gel-purified, by the Gel-purification kit (Promega) and cut by EcoRI and SalI restriction enzymes. The restricted PCR products were ligated into pEGFP-N1 to generate TM7SF3-GFP. Constructs of TM7SF3 tagged with Flag or Myc at the C terminus were generated as follows: TM7SF3-GFP was digested using SalI and NotI restriction enzymes to remove the DNA encoding GFP. The GFP was replaced by a double strand synthetic oligonucleotide, containing matching overhangs of SalI and NotI, coding for immunogenic sequence derived from the c-Myc protein (underlined): S 5′-TCGACATGGAACAAAAGCTCATCTCAGAAGAAGATCTGAATA CGC-3′;AS 5′-GGCCGCGTATTCAGATCTTCTTCTGAGATGAGCTTTTGTTCC ATG-3′. The construct of TM7SF3 tagged with Flag at the C terminus was generated by the proteomics unit at Weizmann institute, using 'restriction site-free cloning'. 57 In brief, primers were designed to contain a tag (Flag or Myc) and overlapping sequences to the TM7SF3 plasmid. These primers were used for whole-plasmid amplification of the insert and the plasmid. The primers used for replacing the c-Myc with Flag in into pEGEF-TM7SF3-Myc are: S 5′-GAGG ACACCCTTGCTTCTGGGTCGACATGGATTACAAGGACGCCGCGACTCTAGATCA TAATCAGCCATAC-3′; AS 5′-GTATGGCTGATTATGATCTAGAGTCGCGGCGTCC TTGTAATCCATGTCGACCCAGAAGCAAGGGTGTCCTC-3′. cells per well, respectively). Twenty -four hours later MIN6 cells were transfected with siRNA SMARTpools using Dharmafect-4 transfection reagent (Dharmacon), according to the manufacturer's instructions. Human Islets, HepG2, U2-OS and HEK293 cells were transfected with siRNA SMARTpools using Dharmafect-1 transfection reagent. Cells were transfected with DNA plasmids using Lipofectamine 2000 transfection reagent (GIBCO-BRL Grand Island, NY, USA) according to the manufacturer's instructions. Cells were then treated as indicated, washed three times with PBS and collected in extraction buffer (25 mM Tris-HCl, 2 mM sodium orthovanadate, 0.5 mM EGTA, 10 mM NaF, 10 mM sodium pyrophosphate, 80 mM β-glycerophosphate, 25 mM NaCl, 1% Triton X-100 and protease inhibitor mixture (diluted 1:1000, pH 7.4)). Cell extracts were centrifuged at 20 000 × g for 15 min at 4°C, and the supernatants were collected. Samples (10-40 μg) were mixed with 5 × Laemmli sample buffer, boiled and resolved by 8% SDS-PAGE under reducing conditions. The proteins were transferred to nitrocellulose membrane for western blotting with the different antibodies.
Assay of caspase 3/7 activity and cellular reducing power. Apoptosis was determined by caspase 3/7 activity kit (Enzolyte-caspase 3-RH110, AnaSpec, Ltd.) using fluorescent microplate reader excitation/ emission = 496/520 nm. Cellular reducing power was determined using the CellTiter-Blue assay kit (Promega) using fluorescent microplate reader excitation/ emission = 480/530 nm.
RNA analysis. Cells were grown in 24-well plates. After treatment, cells were collected and total RNA was extracted using the PerfectPure RNA kit (5Prime, Hamburg, Germany). First-strand cDNA was generated by cDNA Reverse Transcription kit (Applied Biosystems, CA, USA). Quantitive detection of specific mRNA transcripts was carried out by real-time PCR using ABI-Prism 7300 instrument (Applied Biosystems, CA, USA); SYBR Green PCR mix (Invitrogen) and the following oligonucleotide primers: inducible NO synthase (mouse), 5′-GCCCTGCTTTGTGCGAAGTG-3′ and 5′-AGCCCTTTGTGCTGGGAGTC-3′; ATF4(mouse), 5′-CCTTCGACCAGTCGGGTTTG-3′ and 5′-GTCGCTGGAGA ACCCATGAG-3′; CHOP (mouse), 5′-GCAGGAGAACGAGCGGAAAG-3′ and 5′-CTGACCATGCGGTCGATCAG-3′; HPRT (mouse), 5′-GCAGTACAGCCC CAAAATGG-3′ and 5′-GGTCCTTTTCACCAGCAAGCT-3′; p21 (mouse), 5′-CCAGGCCAAGATGGTGTCTT-3′ and 5′-TGAGAAAGGATCAGCCATTGC-3′; TM7SF3 (mouse), 5′-GCCGTCCTGCGCCATATTTC-3′ and 5′-CCCTCTGTCGTT GCCTGTTC-3′; inducible NO synthase (human), 5′-GGTGGAAGCGGTAACA AAGG-3′ and 5′-TGCTTGGTGGCGAAGATGA-3′; ATF4 (human), 5′-CTTA CGTTGCCATGATCCCT-3′ and 5′-CTTCTGGCGGTAGTGG-3′; p21 (mouse), 5′-GGCGGGCTGCATCCA-3′ and 5′-AGTGGTGTCTCGGTGACAAAGTC-3′; TM7SF3 (mouse), 5′-AGTGCTCTCAAGGTGGTTAC-3′ and 5′-GAAACGGGT CCCAAACAATG-3′. Data were normalized for the content of actin or HPRT mRNA levels.
Chromatin Immunoprecipitation. ChIP was performed as described. 58 Immunoprecipitated chromatin was subjected to qPCR analysis using gene-specific primer pairs as follows: TM7SF3 site-1 (4300 bp upstream to the TSS) 5′-GCCACCTGTGTATCTAGGACTACAG-3′ and 5′-CACACAACCAGAAAAAAAA ATTAGC -3′; TM7SF3 site-2 (180 bp upstream to the TSS) 5′-TTGC CTACTTGGTGAGATAAAAGTG-3′ and 5′-GGGAGCCCCCAGGAAGTC-3′; TM7SF3 site-3 (1000 bp downstream (first intron) of the TSS) 5′-TGTGG GAGCCAAGAAGCA-3′ and 5′-AATCATCAAAAATGGTGTACTCATAGG-3′; TM7 SF3 exon, 5′-CATTGTTTGGGACCCGTTTC-3′ and 5′-AAGCGTATGTGTG AGCAGGAA-3′. PCR of the p21 promoter 100 bp upstream of the 5′ p53-res ponsive element was performed on immunoprecipitated chromatin using the following pair of oligonucleotide primers: 5′-AGCAGGCTGTGGCTCTGATT-3′ and 5′-CAAAATAGCCACCAGCCTCTTCT-3′. PCR of the CD95 promoter 610 bp downstream of the TSS was performed on immunoprecipitated chromatin, using the following pair of oligonucleotide primers: 5′-AAGCGGAAGTCTGGGAAGCT-3′ and 5′-CTTGTCCAGGAGTTCCGCTC-3′. PCR of a sequence from GAPDH (exon 4) was performed on immunoprecipitated chromatin, using the following pair of oligonucleotide primers: 5′-GTATTCCCCCAGGTTTACAT-3′ and 5′-TTCTG TCTTCCACTCACTCC-3′.
Densitometry and statistical analysis. The intensity of bands in autoradiograms was determined by densitometry that was carried out on exposures within the linear range. Graphic analysis was performed with NIH image software. Results are presented as means ± S.E.M. For comparison between two groups, a two-sample equal variance Student's t-test (two tailed) was used when appropriate; Po0.05 were considered significant. *, ** and *** correspond to Po0.05, 0.01 and 0.001, respectively.
